Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema

Table 3

Recurrence and retreatment number and times.

	Total	Retreatment	Avg. recurrence time	Second retreatment	Secondary recurrence	Avg. recurrence time 2	Retreatment
Recurrence in 6 months
Group 1	16 eyes	8 (out of 16)	21 ± 2.6 weeks	8 eyes	6 eyes	25 ± 1.3 weeks	2 eyes
Group 2	4 eyes	2 eyes	21 weeks	1 eye
Recurrence > 6 month
	6–12 months
Group 1	20 eyes
Group 2	6 eyes
Recurrence > 6 month
Group 1	20	9	24.2 ± 1.3 weeks	9 eyes	6 eyes	26.4 ± 1.8 weeks	3 eyes
Group 2	6	4	24.16 ± 1.83 weeks	2 eyes	2 eyes	25.1 ± 1.3 weeks	1 eye